NCT01517282 - Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

February 28, 2014

Conditions

Multiple Sclerosis

Interventions

BIOLOGICAL

MOR103

Anti-GM-CSF monoclonal antibody

OTHER

Placebo

Placebo to anti-GM-CSF monoclonal antibody

Trial Locations (5)

Morphosys Investigative Site, Berlin

Morphosys Investigative Site, Gdansk

Morphosys Investigative Site, Poznan

Morhosys Investigative Site, Manchester

MorphoSys Investigative Site, Nottingham